Department of Surgery, Skåne University Hospital, Lund University, Malmö, Sweden.
Department of Surgery, Helsingborg Hospital, Lund University, Helsingborg, Sweden.
Int J Colorectal Dis. 2023 Mar 10;38(1):66. doi: 10.1007/s00384-023-04365-1.
This study aimed to investigate the prognostic effect of tumor deposits (TDs) in lymph node negative rectal cancer.
Patients who had undergone surgery for rectal cancer with curative intention between 2011 and 2014 were extracted from the Swedish Colorectal Cancer Registry. Patients with positive lymph nodes, undisclosed TD status, stage IV disease, non-radical resections, or any outcome (local recurrence (LR), distant metastasis (DM) or mortality) within 90 days after surgery were excluded. TDs status was based on histopathological reports. Cox-regression analyses were used to examine the prognostic impact of TDs on LR, DM, and overall survival (OS) in lymph node-negative rectal cancer.
A total of 5455 patients were assessed for inclusion of which 2667 patients were analyzed, with TDs present in 158 patients. TD-positive patients had a lower 5-year DM-free survival (72.8%, p < 0.0001) and 5-year overall survival (75.9%, p = 0.016), but not 5-year LR-free survival (97.6%) compared to TD-negative patients (90.2%, 83.1% and 95.6%, respectively). In multivariable regression analysis, TDs increased the risk of DM [HR 4.06, 95% CI 2.72-6.06, p < 0.001] and reduced the OS [HR 1.83, 95% CI 1.35-2.48, p < 0.001]. For LR, only univariable regression analysis was performed which showed no increased risk of LR [HR 1.88, 95% CI 0.86-4.11, p = 0.11].
TDs are a negative predictor of DM and OS in lymph node-negative rectal cancer and could be taken into consideration when planning adjuvant treatment.
本研究旨在探讨淋巴结阴性直肠癌中肿瘤沉积物(TDs)的预后作用。
从瑞典结直肠癌登记处提取了 2011 年至 2014 年间接受根治性手术治疗的直肠癌患者。排除了阳性淋巴结、未披露 TD 状态、IV 期疾病、非根治性切除或术后 90 天内出现任何结局(局部复发(LR)、远处转移(DM)或死亡)的患者。TDs 状态基于组织病理学报告。Cox 回归分析用于检查 TDs 对淋巴结阴性直肠癌 LR、DM 和总生存(OS)的预后影响。
共评估了 5455 例患者纳入研究,其中 2667 例患者进行了分析,158 例患者存在 TDs。TD 阳性患者的 5 年无 DM 生存率(72.8%,p<0.0001)和 5 年总生存率(75.9%,p=0.016)较低,而 5 年无 LR 生存率(97.6%)与 TD 阴性患者(90.2%、83.1%和 95.6%)相比没有差异。多变量回归分析显示,TDs 增加了 DM 的风险[HR 4.06,95%CI 2.72-6.06,p<0.001]和降低了 OS[HR 1.83,95%CI 1.35-2.48,p<0.001]。对于 LR,仅进行了单变量回归分析,结果显示 LR 风险没有增加[HR 1.88,95%CI 0.86-4.11,p=0.11]。
TDs 是淋巴结阴性直肠癌中 DM 和 OS 的负预测因子,在计划辅助治疗时可以考虑这一因素。